SEC Form 4 · accession 0001193125-26-354538
Mobia Medical, Inc. · MOBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Casey M Tansey
Director
Period of report
Aug 13, 2026
Accepted (ET)
Aug 17, 2026 · 9:53 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001489993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 13, 2026 | P | 35,572 | $11.5073 | A | 268,904 | D | |
| Common StockF2 | Aug 14, 2026 | P | 15,721 | $11.65 | A | 284,625 | D | |
| Common Stock | Aug 14, 2026 | P | 100 | $12.53 | A | 284,725 | D | |
| Common StockF3 | Aug 17, 2026 | P | 17,166 | $11.8509 | A | 301,891 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.33 to $11.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.42 to $12.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.675 to $12.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.